3.38 USD
↗ 0.07 (2.11%)AT CLOSE (11:59 AM EDT)
Mannkind Corporation
MNKDNASDAQ • USD
3.40
↗ 0.02 (0.53%)
POST MARKET (AS OF 08:00 PM EDT)
Post Market
AS OF 08:00 PM EDT
3.40
↗ 0.02 (0.53%)
Market: CLOSED
Open?$3.32
High?$3.47
Low?$3.32
Prev. Close?$3.31
Volume?4.6M
Avg. Volume?5.7M
VWAP?$3.39
Rel. Volume?0.81x
Bid / Ask
Bid?$3.35 × 300
Ask?$3.82 × 100
Spread?$0.47
Midpoint?$3.59
Valuation & Ratios
Market Cap?1.0B
Shares Out?309.0M
Float?299.1M
Float %?97.4%
P/E Ratio?178.11
P/B Ratio?-20.47
EPS?$0.02
Dividend?0.00%
Ex-Dividend?N/A
Mannkind Corporation (MNKD) trades at $3.38 per share. MNKD shows a split signal: technical indicators suggest "Strong Buy" while underlying fundamentals indicate "Sell". Notable factors include a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bearish Death Cross on the long-term moving averages. Valuation metrics place MNKD at a fair price relative to peers.
Technical & fundamental data as of May 22, 2026.
News
Profile
MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.
Employees
592
Market Cap
1.0B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2004-07-28
Address
1 CASPER STREET
DANBURY, CT 06810
Phone: 818-661-5000
DANBURY, CT 06810
Phone: 818-661-5000
Technical OutlookStrong Buy
Strong SellNeutralStrong Buy
Long-Term (Tide)?▲ Bullish(+1/3)
Medium-Term (Wave)?▲ Bullish(+3/3)
Short-Term (Ripple)?▲ Bullish(+3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?0
Momentum?62
Short Sent.?34
Piotroski F-Score?1/9Weak
Altman Z-Score?-4.09Distress
Confidence?58%Low
Short InterestHigh
Short % of Float?9.94%Elevated
Short Interest?29.7M
Days to Cover?7.9
Free Float299.1M
Avg Daily Volume3.8M
Settlement Date2026-04-30
Financial Health
Current Ratio?1.70Adequate
Quick Ratio?1.50Adequate
Cash Ratio?0.44Low
Debt/Equity?-8.98Low
ValuationFAIRLY VALUEDvs 1 peers + S&P 500
Score61/100
P/E?178.1PRICEY▾
Peers100
S&P3
P/B?-20.47CHEAP▾
S&P97
P/S?2.99CHEAP▾
Peers100
S&P51
P/FCF?76.3PRICEY▾
Peers100
S&P3
EV/EBITDA?24.3HIGH▾
Peers100
S&P17
EV/Sales?4.09FAIR▾
Peers100
S&P46
Returns & Efficiency
ROE?-11.5%WEAK▾
S&P9
ROA?0.7%WEAK▾
Peers50
S&P10
Cash Flow & Enterprise
FCF?$13.7M
Enterprise Value?$1.4B
Fundamentals ratios updated end of day